137 related articles for article (PubMed ID: 9029104)
1. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
Donohoe ME; Blomberg BB
J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
[TBL] [Abstract][Full Text] [Related]
2. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene.
Okabe T; Bauer SR; Kudo A
Eur J Immunol; 1992 Jan; 22(1):31-6. PubMed ID: 1730257
[TBL] [Abstract][Full Text] [Related]
3. The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are co-expressed during B cell development.
Dul JL; Argon Y; Winkler T; ten Boekel E; Melchers F; Mårtensson IL
Eur J Immunol; 1996 Apr; 26(4):906-13. PubMed ID: 8625987
[TBL] [Abstract][Full Text] [Related]
4. Identification and localization of a developmental stage-specific promoter activity from the murine lambda 5 gene.
Yang J; Glozak MA; Blomberg BB
J Immunol; 1995 Sep; 155(5):2498-514. PubMed ID: 7650380
[TBL] [Abstract][Full Text] [Related]
5. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
6. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
[TBL] [Abstract][Full Text] [Related]
7. A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene.
Okabe T; Watanabe T; Kudo A
Eur J Immunol; 1992 Jan; 22(1):37-43. PubMed ID: 1730258
[TBL] [Abstract][Full Text] [Related]
8. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
Kitamura D; Roes J; Kühn R; Rajewsky K
Nature; 1991 Apr; 350(6317):423-6. PubMed ID: 1901381
[TBL] [Abstract][Full Text] [Related]
9. Mapping and functional analysis of regulatory sequences in the mouse lambda5-VpreB1 domain.
Minaee S; Farmer D; Georgiou A; Sabbattini P; Webster Z; Chow CM; Dillon N
Mol Immunol; 2005 Jul; 42(11):1283-92. PubMed ID: 15950724
[TBL] [Abstract][Full Text] [Related]
10. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
Licence S; Persson C; Mundt C; Mårtensson IL
Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
[TBL] [Abstract][Full Text] [Related]
11. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression.
Guelpa-Fonlupt V; Tonnelle C; Blaise D; Fougereau M; Fumoux F
Eur J Immunol; 1994 Jan; 24(1):257-64. PubMed ID: 8020565
[TBL] [Abstract][Full Text] [Related]
12. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression.
Wang YH; Nomura J; Faye-Petersen OM; Cooper MD
J Immunol; 1998 Aug; 161(3):1132-9. PubMed ID: 9686571
[TBL] [Abstract][Full Text] [Related]
13. Expression of surrogate light chain in common variable immunodeficiency.
Yano M; Kondo N; Kato Y; Shinoda S; Inoue R; Orii T
Exp Clin Immunogenet; 1995; 12(1):1-9. PubMed ID: 7710759
[TBL] [Abstract][Full Text] [Related]
14. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of full-length and truncated Ig mu-chains in human B lymphocytes results from alternative splicing of a single primary RNA transcript.
Caldwell J; McElhone P; Brokaw J; Anker R; Pollok BA
J Immunol; 1991 Jun; 146(12):4344-51. PubMed ID: 1904080
[TBL] [Abstract][Full Text] [Related]
16. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
[TBL] [Abstract][Full Text] [Related]
17. Gene conversion events contribute to the polymorphic variation of the surrogate light chain gene lambda 5/14.1.
Conley ME; Rapalus L; Boylin EC; Rohrer J; Minegishi Y
Clin Immunol; 1999 Nov; 93(2):162-7. PubMed ID: 10527692
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific deoxyribonuclease I-hypersensitive sites in the vicinity of the immunoglobulin C lambda cluster of man.
Asenbauer H; Klobeck HG
Eur J Immunol; 1996 Jan; 26(1):142-50. PubMed ID: 8566057
[TBL] [Abstract][Full Text] [Related]
19. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
van Loo PF; Dingjan GM; Maas A; Hendriks RW
Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
[TBL] [Abstract][Full Text] [Related]
20. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
